60 seconds with Jamie Cargill
The clinical lead nurse at Bristol Haematology and Oncology Centre and Chair of TYAC talks to us about his career, plans and interests.
The clinical lead nurse at Bristol Haematology and Oncology Centre and Chair of TYAC talks to us about his career, plans and interests.
Sheila Cartwright, one of the first CCLG members and retired paediatric radiation oncologist, reflects on her career, and explains how LinkedIn allows her to keep up with developments in childhood cancer and reconnect with former patients.
Rachel Corbett’s daughter, Suki, was diagnosed with acute lymphoblastic leukaemia (ALL) in January 2017, aged four. Rachel writes about spending Christmas in hospital and how the experience has changed how her and her family think of it.
Prof Louis Chesler leads the Paediatric Oncology Experimental Medicine (POEM) Centre at the Institute of Cancer Research (ICR). He tells us about some of the exciting digital innovations that have the potential to transform childhood cancer treatment.
With the COVID-19 pandemic delaying many of its plans, Teenagers and Young Adults with Cancer (TYAC), CCLG’s sister organisation, has revisited its ambitious 2020-2025 strategic plan. Ashley Ball-Gamble, CEO of TYAC and CCLG, explains more.
Ellie Waters, 20, is a digital content creator who was diagnosed with rhabdomyosarcoma, aged 14. She tells us how she began creating digital content to share her experiences and help raise awareness of childhood cancer and its effects.
Dr Bob Phillips, Senior Academic Consultant at University of York, Consultant Paediatric Oncologist at Leeds Children’s Hospital and CCLG member, writes...
Imaging is central to diagnosing and monitoring solid cancers and scans are a key part of the patient and family journey. Different types of scans such as CT, MRI and PET, have all become commonplace in hospitals throughout the UK and children benefit from the accurate high-quality images they produce.
Naomi Shefford-Thomas, CCLG Information Executive and mum to Phoebe, who underwent almost four years of treatment for neuroblastoma, answers your questions.